Tag: Pharmaceuticals
-
Four weeks before 100 percent Section 232 pharmaceutical tariffs extend to every importer, smaller drugmakers race for US manufacturing capacity, exemption deals, and answers WASHINGTON, September 1, 2026: With the calendar turning to September, the pharmaceutical industry entered the final four weeks before the most consequential deadline in modern drug trade policy: on September 29,…
-
China and Switzerland conclude an upgraded free trade agreement scrapping tariffs on 99.8 percent of Swiss exports, a pact analysts read as Beijing’s pointed signal to a wary European Union BERN, Aug. 26: China and Switzerland have concluded negotiations to upgrade their twelve-year-old free trade agreement, a deal that will eventually eliminate tariffs on 99.8…
-
China and Switzerland conclude an upgraded free trade agreement scrapping tariffs on 99.8 percent of Swiss exports, a pact analysts read as Beijing’s pointed signal to a wary European Union BERN, Aug. 26: China and Switzerland have concluded negotiations to upgrade their twelve-year-old free trade agreement, a deal that will eventually eliminate tariffs on 99.8…
-
India’s trade remedies authority is running one of its busiest anti-dumping dockets in memory this August, with hearings, recommendations and new probes overwhelmingly targeting Chinese goods across chemicals, steel, electronics and pharmaceuticals. NEW DELHI, August 14, 2026 India’s Directorate General of Trade Remedies convened an oral hearing on Friday afternoon in its anti-dumping investigation into…
-
The public comment window closed Monday in the U.S. Trade Representative’s Section 301 investigation into Germany’s pharmaceutical pricing, hardening battle lines in a novel trade fight that could put tariffs on one of the world’s most sensitive industries. WASHINGTON, Aug. 12, 2026 A first of its kind American trade investigation into how a close ally…
-
Comments are due tonight in the USTR’s Section 301 investigation of German pharmaceutical pricing, a case that could put tariffs behind Washington’s demand that wealthy allies pay more for American medicines WASHINGTON, Aug. 10, 2026 The public comment period in one of the most closely watched trade investigations of the year closes tonight at 11:59…
-
America’s 100 percent tariff on patented drug imports is now live for the industry’s biggest importers, and the first full business week under the new regime is testing supply chains, pricing models and Washington’s onshoring bet all at once. WASHINGTON, Aug. 3, 2026 – The most aggressive pharmaceutical trade action in modern American history is…
-
America’s 100 percent pharmaceutical tariff is now the law of the land for the industry’s biggest names, and the rest of the sector has eight weeks to find shelter before the same duty lands on them WASHINGTON, August 4, 2026. The most aggressive sector-specific tariff in modern American trade history is no longer a threat,…
-
A two year countdown on generic drug tariffs formally began Saturday, giving the manufacturers of nine in ten American prescriptions until August 2028 to build in the United States or face duties of 100 percent, then 200 percent. WASHINGTON, Aug. 2, 2026. The most consequential tariff of the week is one that, for now, collects…
-
One day before the steepest pharmaceutical tariffs in modern American history take effect, the world’s largest drugmakers are racing to lock in agreements that would spare them a 100 percent duty on patented medicines WASHINGTON, July 30, 2026. The United States stands one day away from the most consequential deadline in the modern history of…